Close

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases May 24, 2021 04:58PM
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP Sep 23, 2020 10:38AM
Form 4 Strongbridge Biopharma For: Dec 26 Filed by: CAXTON CORP Dec 28, 2018 05:40PM
Form 4 Strongbridge Biopharma For: Dec 20 Filed by: CAXTON CORP Dec 21, 2018 06:17PM
Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP Aug 27, 2018 04:08PM


Aug 9, 2018 12:36PM Strongbridge Biopharma (SBBP) 10% Owner Buys ~361K Shares
Aug 9, 2018 12:29PM Form 4 Strongbridge Biopharma For: Aug 08 Filed by: CAXTON CORP
Aug 1, 2018 04:59PM Form 4 Strongbridge Biopharma For: Jul 30 Filed by: CAXTON CORP
Jul 27, 2018 06:17PM Form 4 Strongbridge Biopharma For: Jul 24 Filed by: CAXTON CORP
Jul 23, 2018 05:33PM Form 4 Strongbridge Biopharma For: Jul 19 Filed by: CAXTON CORP
Jul 18, 2018 01:56PM Form 4 Strongbridge Biopharma For: Jul 16 Filed by: CAXTON CORP
Oct 10, 2017 12:35PM Form SC 13D/A Strongbridge Biopharma Filed by: CAXTON CORP
Dec 30, 2016 12:45PM Form SC 13D Strongbridge Biopharma Filed by: CAXTON CORP